The British Journal of Clinical Pharmacology (BJCP) has retracted a 2015 paper about treating heart failure after deciding its peer review process had been compromised.
This paper is one of the many we’ve noticed lately that have been felled by the actions of a “third party” — in this case, a manuscript editing company called EditPub.
The newly retracted paper, “rhBNP therapy can improve clinical outcomes and reduce in-hospital mortality compared with dobutamine in heart failure patients: a meta-analysis,” has not yet been cited, according to Thomson Reuters Web of Science.
Here’s the retraction note, which tells us a bit more: Continue reading Pharmacology journal pulls paper because third party “compromised” peer review